PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Sinclair & Co.

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Senior Formulations Scientist at Metrics Earns CPIP Credential - Joseph E. “Joe” Cobb Jr., senior formulations scientist at Metrics, Inc., has earned the highly respected Certified Pharmaceutical Industry Professional™ (CPIP™) credential
Senior Formulations Scientist at Metrics Earns CPIP Credential

 

NewswireToday - /newswire/ - Raleigh, NC, United States, 2010/10/07 - Joseph E. “Joe” Cobb Jr., senior formulations scientist at Metrics, Inc., has earned the highly respected Certified Pharmaceutical Industry Professional™ (CPIP™) credential.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Awarded by the ISPE Professional Certification Commission, the CPIP credential is the only competency-based international certification for pharmaceutical professionals. It holds those who qualify to a global competency standard through demonstrated education, experience and a rigorous examination.

“Through their work and research, Metrics employees continually strive to advance scientific knowledge and understanding,” said Phil Hodges, president of Metrics Inc. “Their commitment to good science is reflected by their desire to exceed industry expectations and standards – just like Joe has done by earning CPIP certification. I congratulate Joe on his impressive achievement.”

As senior formulations scientist, Cobb manages all aspects of projects at Metrics that involve early-phase solid oral dosage development. Some of those projects involve novel delivery systems such as rapid-dissolve technologies, modified release tablets and multi-particulate applications.

With nearly 20 years of industry experience, Cobb joined Metrics in 2002, where he oversees formulation development, scale-up and commercial process validation for new drug application (NDA) and investigational new drug application (IND) submissions.

The holder of a U.S. patent for a pharmaceutical application, Cobb has authored several posters presented during annual conferences of the American Association of Pharmaceutical Sciences. He received his bachelor’s of science degree in chemical engineering from The Ohio State University.

Metrics, Inc. (metricsinc.com) is one of the most respected contract pharmaceutical development and manufacturing companies in the United States today.

Started as an analytical laboratory in 1994, Metrics has evolved into a full-service provider of quality pharmaceutical formulation development; first-time-in-man (FTIM) formulations; clinical material manufacturing (CTM) for Phase I, II and III trials; commercial manufacturing; and analytical method development and validation services.

Metrics has particular expertise in FTIM and Phase I, II, and III studies, having conducted more than 120 FTIM studies for different chemical entities in the last five years alone – while developing more than 700 batches of CTM in the same period.

The International Society of Pharmaceutical Engineers (ISPE) is an independent membership organization of 22,000 pharmaceutical manufacturing professionals from 90 countries. ISPE aims to be the catalyst for engineering pharmaceutical innovation by providing members opportunities to develop technical knowledge, exchange practical experience within their community, enhance their professional skills and collaborate with global regulatory agencies and industry leaders.

The ISPE Professional Certification Commission is an autonomous governing body that develops certification programs to benefit professionals and their employers, as well as government, academe and the public health product consumer. The PCC’s commissioners include senior-level industry professionals, academic leaders, representatives from government regulatory agencies and members of the general public.

Contact for Metrics: Jeff Basham, VP Business Development, 252.317.3880
Contact for ISPE: Danielle Hould, Communications Manager, 813.960.2105 x277

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Sinclair & Co.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Senior Formulations Scientist at Metrics Earns CPIP Credential

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Karen Stinneford - Sinclair-Co.com 
919-833-9102 kstinneford[.]sinclair-co.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Sinclair & Co. securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Sinclair & Co. / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

U.S. FDA Approves New Indication for Ipsen’s Somatuline® Depot (lanreotide) Injection for the Treatment of Carcinoid Syndrome
Genentech Provides Update on First Lampalizumab Phase III Study for Geographic Atrophy, an Advanced Form of Age-Related Macular Degeneration
mProve Health and Greenphire Partner to Deliver a First-of-its-Kind Patient Engagement Solution
FDA Approves Genentech’s Actemra (Tocilizumab) for the Treatment of CAR T Cell-Induced Cytokine Release Syndrome
Greenphire Named to Inc. 5000 for Fifth Consecutive Year
Five Community Health Centers Honored for Innovative Approaches to Medication Therapy Management
FDA Grants Priority Review for Genentech’s Gazyva in Previously Untreated Follicular Lymphoma
ProSci Incorporates Flow Cytometry Screening to Custom Monoclonal Antibody Service
FDA Grants Priority Review to Genentech's Emicizumab for Hemophilia A with Inhibitors
BD Expands Suite of Blood Culture Offerings with New BD BACTEC™ Standard Aerobic & Standard Anaerobic Plastic Bottles
Twist Bioscience Collaborates with Synbio Technologies to Supply Long DNA to Customers
FDA Grants Priority Review and Breakthrough Therapy Designation for Zelboraf (vemurafenib) in Erdheim-Chester Disease with BRAF V600 Mutation
Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (telotristat Ethyl)
BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System
Positive Phase III Results for Genentech’s Emicizumab in Hemophilia A Published in The New England Journal of Medicine

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  NAKIVO, Inc.

Visit  La Bella Bakery Artisan Bakery Arizona





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)